Microbot Medical MBOT Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $105K— | —— | —— | —— | —— | ||
| $103K— | —— | —— | —— | —— | ||
| $2K— | —— | —— | —— | —— | ||
| 1.9%— | —— | —— | —— | —— | ||
| $1.29M-16.1% | $1.54M+31.7% | $1.17M-44.5% | $2.11M+44.7% | $1.46M-26.5% | ||
| $3.03M— | —— | —— | —— | $1.56M+25.1% | ||
| -$4.32M-4.4% | -$4.14M-7.2% | -$3.86M-3.7% | -$3.72M-23.2% | -$3.02M+11.9% | ||
| -4,114.3%— | —— | —— | —— | —— | ||
| $649K-3.7% | $674K+137% | $284K+27.4% | $223K+114% | $104K+174% | ||
| —— | —— | —— | —— | $316K— | ||
| —— | 0%— | —— | —— | —— | ||
| -$3.67M-6.0% | -$3.46M+3.2% | -$3.58M-2.2% | -$3.5M-34.6% | -$2.6M+23.3% | ||
| -3,496.2%— | —— | —— | —— | —— | ||
| -$0.05-25.0% | -$0.04+42.9% | -$0.07+30.0% | -$0.10-25.0% | -$0.08+60.0% | ||
| -$4.31M-4.4% | -$4.13M-7.2% | -$3.85M-3.8% | -$3.71M-23.5% | -$3.01M+11.7% | ||
| -4,102.9%— | —— | —— | —— | —— | ||
| -$4.32M-4.4% | -$4.14M-7.2% | -$3.86M-3.7% | -$3.72M-23.2% | -$3.02M+11.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Microbot Medical's revenue?
- Microbot Medical (MBOT) generated $190.2K in revenue over the trailing twelve months, up 62.4% year over year.
- Is Microbot Medical profitable?
- Microbot Medical is not currently profitable: it reported a net loss of $14.2M over the trailing twelve months, a -3669.9% net margin.
- What is Microbot Medical's earnings per share?
- Microbot Medical's diluted EPS over the trailing twelve months is $-0.26.
- Where does Microbot Medical's income statement data come from?
- Every line is extracted from Microbot Medical's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
